The current consensus includes 4 well-recognized molecular types; WNT-activated-Medulloblastoma, SHH-activated-Medulloblastoma with and without TP53 mutation, and the others classified under the “non-WNT/non-SHH group. The gene discussed is SHH; the disease is medulloblastoma.